Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

766.60INR
11:07am IST
Change (% chg)

Rs12.15 (+1.61%)
Prev Close
Rs754.45
Open
Rs754.00
Day's High
Rs768.00
Day's Low
Rs750.95
Volume
824,625
Avg. Vol
1,945,761
52-wk High
Rs986.10
52-wk Low
Rs697.20

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: 0.01
Market Cap(Mil.): Rs331,652.69
Shares Outstanding(Mil.): 452.58
Dividend: 5.00
Yield (%): 0.68

Financials

  LUPN.NS Industry Sector
P/E (TTM): 54.85 32.68 37.43
EPS (TTM): 13.36 -- --
ROI: 2.87 12.50 12.14
ROE: 4.44 13.81 17.05

BUZZ-Lupin falls after U.S. FDA classification of Goa plant, potential approval curbs

** Indian drugmaker Lupin Ltd's shares fall as much as 5.7% to 720 rupees - lowest since March 28

27 May 2019

BUZZ-India's Lupin falls close to 7-week low on Q4 profit miss

** Shares of Lupin Ltd fall as much as 5.9% to 736.40 rupees, touches a level close to 7-week low after the pharma co posted qtrly results below estimates

16 May 2019

BUZZ-India's Lupin shares fall on potential U.S. FDA admin action on plant

** Drugmaker Lupin Ltd' shares fall as much as 3.8 pct to 835 rupees, their biggest daily pct drop since March 18

24 Apr 2019

BUZZ-India's Lupin rises on Morgan Stanley upgrade

** Shares of Lupin Ltd rise as much as 4.5 pct to 868.95 rupees, their biggest intraday pct gain since Oct. 29, 2018

23 Apr 2019

RPT-ICRA ratings for Indian debt instruments-Feb 26

(Repeating to add more ratings.) Feb 26 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of February 25, 2019. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: -------------

27 Feb 2019

Lupin posts third-quarter loss on charge related to blood pressure drug

Indian drugmaker Lupin Ltd posted a surprise quarterly loss on Wednesday after taking a one-time charge related to litigation over a blood pressure drug.

06 Feb 2019

UPDATE 1-India's Lupin posts Q3 loss on charge related to blood pressure drug

Feb 6 Indian drugmaker Lupin Ltd posted a surprise quarterly loss on Wednesday after taking a one-time charge related to litigation over a blood pressure drug.

06 Feb 2019

India's Lupin posts quarterly loss on one-off charge

Feb 6 Indian drugmaker Lupin Ltd posted a surprise third-quarter loss on Wednesday, due to a one-off charge in the quarter.

06 Feb 2019

Earnings vs. Estimates